Warfarin sodium(129-06-6)
Warfarin sodium tablets, indications for patients requiring long-term continuous anticoagulation: (1) to prevent the formation and development of thrombosis, for the treatment of thromboembolic disease; (2) to treat venous thrombosis after surgery or trauma, and as an adjunct to myocardial infarction; (3) for prophylactic use in patients with previous thromboembolic disease and those at risk of postoperative thrombotic complications.
classification：
Product Center
Key words:
Product Description
Warfarin sodium tablets, indications for patients requiring long-term continuous anticoagulation: (1) to prevent the formation and development of thrombosis, for the treatment of thromboembolic disease; (2) to treat venous thrombosis after surgery or trauma, and as an adjunct to myocardial infarction; (3) for prophylactic use in patients with previous thromboembolic disease and those at risk of postoperative thrombotic complications.
Chemical name: 3-(α-acetonylbenzyl)4-hydroxycoumarin
Chemical structure formula:
Molecular formula: C19H15NaO4
Molecular weight: 330.31
Characteristic
This product is sugar-coated tablets, appearing white after removing the coating.
Usage and dosage
Oral dosage for adults: avoid shock treatment, 3-4mg for the first 3 days (half dosage for old and weak patients and diabetic patients), and 2.5-5mg for maintenance after 3 days (the dosage can be adjusted with reference to the clotting time to make the INR value reach 2~3). Because of the slow onset of action of this product, the plasma anticoagulant cells are inhibited in the first 3 days of treatment, there may be a transient hypercoagulable state, if the anticoagulant effect must be produced immediately, heparin can be applied at the same time at the beginning, and then discontinue heparin after the anticoagulant effect of this product is fully developed.
Related products
Message
Contacts
© COPYRIGHT 2023 Wuhan Shiji Pharmaceutical Co.,Ltd. ALL RIGHTS RESERVED | Business license | SEO | Powered by www.300.cn